My presentation today is on the new treatments for acute myeloid and lymphoid leukaemias. I am focussing on the new molecular studies that have been done and the trials and new agents that are used to treat these diseases. Initially we had chemotherapy as the only modality, now we have targeted molecular trials to treat these patients. We also have new immunotherapy available to treat these patients and I’ll be presenting about that today.